Clinical Indication

IgM paraproteinaemic demyelinating peripheral neuropathy in adults


Approved centres only. LLR is currently not an approved centre.

Date of classification

February 2022

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety